Patents expiring in 2031

US 7943772

Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

Theravance, Inc. · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943626

Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

Takeda Pharmaceutical Company Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947810

Kits for diagnosing a hypophosphatemic disorder

Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947822

HIV vaccines based on Env of multiple clades of HIV

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947710

Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947289

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947737

Method of treating hypertension and reducing serum lipase activity

Aker Biomarine AS · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947720

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Pharmacopeia Drug Discovery, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947659

iRNA agents targeting VEGF

Alnylam Pharmaceuticals, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947651

Secreted frizzled related protein, sFRP, fragments and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947681

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947261

Conjugates formed from polymer derivatives having particular atom arrangements

Nektar Therapeutics · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947649

Liquid buffered GDF-5 formulations

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947698

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7947726

Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof

The Regents of the University of California · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951770

Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

Northwestern University · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951851

Curable composition for dental purposes

Kuraray Medical Inc. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951362

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951817

Pyridomorphinans, pyridazinomorphinans and use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951845

Composition and method of treating hearing loss

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951579

Method for bacteriophage delivery and amplification

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951557

Human lysosomal proteins from plant cell culture

Protalix Ltd. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951543

Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

SureGene LLC · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951786

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951383

Attenuated parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951356

Tissue factor compositions and kits for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951390

Slow-release microcapsule composition for safe delivery of agriculturally active material

United Phosphorus Limited · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951787

Phosphoramidate compounds and methods of use

Cardiff Protides Limited · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951820

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951925

Methods and compositions for gene inactivation

Sangamo Biosciences, Inc. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951909

Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide

United Biomedical, Inc. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951831

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

The Regents of the University of California · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951809

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951805

Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

Xenon Pharmaceuticals Inc. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7951548

IL-13 production inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956086

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956220

MAO-B inhibitors useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956177

dsRNA compositions and methods for treating HPV infection

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956052

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7955602

Annexin proteins and autoantibodies as serum markers for cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956028

Protein stabilization formulations

JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7955596

B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

UNIVERSITY OF CONNECTICUT · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956054

Dual-acting pyrazole antihypertensive agents

Theravance, Inc. · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960535

Recombinant lipidated PsaA protein, methods of preparation and use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960505

Lantibiotics and uses thereof

Regents of the University of Minnesota · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960502

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960415

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960385

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)